Product Name: Gadobutrol
Description: Gadobutrol is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and in the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations. Gadobutrol is marketed by Bayer Schering Pharma as Gadovi
CAS NO: 853-23-6 Product: Dehydroisoandrosterone 3-acetate
Synonym: Gd-DO3A-butrol; ZK 135079; Gadobutrol, Gadograf; Gadovist, Gadavist.
IUPAC Chemical Name: gadolinium(III) 2,2,2-(10-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
SMILE Code: OC[[email protected]@H](O)[[email protected]](N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1)CO.[Gd+3]
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO.
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:
Chemical Formulaļ¼šC18H31GdN4O9
ExactMass: 605.1332
Molecular Weight: 604.71
Elemental Analysis: C, 35.75; H, 5.17; Gd, 26.00; N, 9.27; O, 23.81